Description: BBS-Bioactive Bone Substitutes Oyj, a biomedical technology company, develops, manufactures, and commercializes bioactive medical devices and implants for orthopedic surgery in Finland. The company offers ARTEBONE, an orthobiological product based on tricalcium phosphate and natural spectrum of bone proteins used primarily for the treatment of bone defects and healing problems in extremities, such as foot and ankle. BBS-Bioactive Bone Substitutes Plc was incorporated in 1991 and is headquartered in Oulu, Finland.
Home Page: www.bbs-artebone.fi
Kiviharjunlenkki 6
Oulu,
90220
Finland
Phone:
358 4070 80307
Officers
| Name | Title |
|---|---|
| Prof. Ilkka Kangasniemi | Chief Exec. Officer |
| Mr. Jari Kortesluoma M.sc. | Chief Financial Officer |
| Mr. Paul C. Watkins | Chief Commercial Officer & Member of Advisory Board |
| Jussi Jukka | Head of Production |
Exchange: HE
Country: FI
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.1029 |
| Price-to-Sales TTM: | 1123.2206 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 21 |